A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report

被引：0

作者：

Merhaben, Salma ^{[1
]}

Ayadi, Shema ^{[1
]}

Tangour, Monia ^{[2
]}

Boujelbene, Nadia ^{[2
]}

Ghariani, Rayfa ^{[3
]}

Mouelhi, Leila ^{[1
]}

Merhaben, Fathi ^{[4
]}

机构：

[1] Charles Nicolle Hosp, Gastroenterol Dept, Tunis 1006, Tunisia

[2] Salah Azaiez Inst, Histopathol Dept, Tunis 1007, Tunisia

[3] El Amen Private Hosp, Radiol Dept, Nabeul 8000, Tunisia

[4] El Amen Private Hosp, Gastroenterol Dept, Nabeul 8000, Tunisia

来源：

FUTURE SCIENCE OA | 2023年

关键词：

anti-TNF therapy; Crohn's disease; diffuse large -B cell lymphoma; primary hepatic lymphoma; thiopurine;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Primary hepatic lymphoma is a rare variant of non-Hodgkin's lymphoma with an incidence of 0.016% of all non-Hodgkin lymphomas. The most common histologic subtype is large diffuse B-cell lymphoma. Pathogenesis is not clearly established and undergoing immunosuppressive therapy has been proposed as a risk factor for primary hepatic lymphoma. We report an intriguing case study, featuring a 23-year-old male patient with Crohn's Disease who had been receiving a combination therapy of thiopurine and anti-TNF for 6 years and was diagnosed with primary hepatic diffuse large B-cell lymphoma.

引用

页数：7

共 50 条

[31] SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN'S DISEASE
Rezik, Mohamed
Mattina, Deirdre
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1042 - 1042
[32] Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease
Desai, Alka A.
Marks, Daniel J. B.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 695 - 699
[33] Anti-TNF Treatment in Crohn's Disease: Toward Tailored Therapy?
D'Haens, Geert
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1140 - 1141
[34] Practical Application of Anti-TNF Therapy for Luminal Crohn's Disease
Kamm, Michael A.
Ng, Siew C.
De Cruz, Peter
Allen, Patrick
Hanauer, Stephen B.
INFLAMMATORY BOWEL DISEASES, 2011, 17 (11) : 2366 - 2391
[35] Anti-TNF antibody therapy in Crohn's disease: the risk of a switch
Ricart, Elena
Ordas, Ingrid
Panes, Julian
GUT, 2012, 61 (02) : 169 - 170
[36] Effects of anti-TNF? treatment on Crohn's disease induced hepatic steatosis
Manka, Paul Peter
Sydor, Svenja
Von Arnim, Ulrike
Link, Alexander
Vilchez-Vargas, Ramiro
Helbeck, Annika
Brandenburg, Malte
Kinner, Sonja
Li, Yan
Canbay, Ali
Kahraman, Alisan
Wedemeyer, Heiner
Bechmann, Lars
JOURNAL OF HEPATOLOGY, 2020, 73 : S239 - S240
[37] Case Series of Crohn's Disease Patients Refractory to Anti-TNF Alpha Therapy on Uztekinumab
Siddiqui, Mohammad
Shaikh, Amna
Iqbal, Umair
Schairer, Jason
Kaur, Nirmal
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1477 - S1477
[38] Hepatosplenic T-Cell Lymphoma in Patient With Crohn's Disease Receiving Immunomodulator Therapy: A Case Report
Pointer, Lauren
Mendez, Vanessa
Regenstein, Fredric G.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1215 - S1216
[39] Intestinal Tuberculosis Masquerading as Crohn's Disease? A Case of Disseminated Tuberculosis after Anti-TNF Therapy for Suspected Crohn's Disease
Abadir, Alexander P.
Han, James Y.
Youssef, Fady A.
CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2019, 2019
[40] Efficacy of ustekinumab in patient with Crohn's disease and anti-TNF induced psoriasis
Moreno-Suarez, Fatima
del Carmen Salazar-Nievas, Maria
Aceituno-Madera, Pedro
Bautista-Martinez, Pablo
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB121 - AB121

← 1 2 3 4 5 →